NeuroSense Therapeutics Investor Relations Material
Latest events
Q4 2024
7 Apr, 2025
Q3 2024
18 Dec, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeuroSense Therapeutics Ltd
Access all reports
NeuroSense Therapeutics Ltd is a biotechnology company focused on developing treatments for neurodegenerative diseases. The company specializes in multi-target drug therapies designed to address conditions such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and Alzheimer’s disease. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
NRSN
Country
🇺🇸 United States